Abstract
Deoxyribonuclease I (DNaseI) is an endonuclease that facilitates chromatin breakdown and promotes susceptibility to autoimmune disorders. The aim of study was to investigate serum DNase I activity in patients with inflammatory bowel diseases (IBD).